Joseph L. Goldstein

Director, Regeneron Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 2, 2026Granted 155 shares of Regeneron Pharmaceuticals²
Jan 2, 2025Granted 166 shares of Regeneron Pharmaceuticals³
Jan 23, 2024Sold 2,707 shares at $950.00 of Regeneron Pharmaceuticals⁴
Jan 23, 2024Exercised options 2,707 shares at $625.60 of Regeneron Pharmaceuticals⁴
Jan 2, 2024Granted 135 shares of Regeneron Pharmaceuticals⁵
Feb 6, 2023Sold 3,613 shares at $800.00 of Regeneron Pharmaceuticals⁶
Feb 6, 2023Exercised options 3,613 shares at $482.68 of Regeneron Pharmaceuticals⁶
Jan 3, 2023Granted 165 shares of Regeneron Pharmaceuticals⁷
Mar 30, 2022Sold 2,431 shares at $700.00 of Regeneron Pharmaceuticals⁸
Mar 30, 2022Exercised options 2,431 shares at $374.12 of Regeneron Pharmaceuticals⁸
Jan 3, 2022Granted 191 shares of Regeneron Pharmaceuticals⁹

The numbers on this page point here. Each one links to the record it came from.